20170619-三星证券-Samsung_Healthcare_Weekly_16页_1mb

报告摘要

Samsung Healthcare Weekly Summary

Core Content Overview

This document provides a detailed analysis of the global healthcare sector, focusing on key indices and individual companies across various sub-sectors. It includes performance metrics, forward P/E ratios, P/B ratios, and market share data, primarily sourced from QuantiWise, Bloomberg, and Samsung Securities.

Key Indices and Performance

Global Healthcare Indices

Korea:
- KRX Health Care: Forward P/E 37.1, portion of market cap 5.3%, 1-week performance (0.9)%, 1-month 8.1%, 3-month 17.5%, YTD 9.9%.
- Kospi Medical Supplies: Forward P/E 50.3, portion of market cap 2.5%, 1-week performance (0.2)%, 1-month 12.8%, 3-month 23.3%, YTD 25.1%.
- Kosdaq Pharmaceuticals: Forward P/E 27.9, portion of market cap 2.2%, 1-week performance 0.2%, 1-month 6.9%, 3-month 14.5%, YTD 5.5%.
- Kosdaq Medical and Precision Machines: Forward P/E 15.2, portion of market cap 0.4%, 1-week performance (0.7)%, 1-month (1.1)%, 3-month 2.2%, YTD (6.0)%.
US:
- S&P 500 Healthcare: Forward P/E 16.8, portion of market cap 8.5%, 1-week performance 0.5%, 1-month 3.8%, 3-month 3.3%, YTD 12.8%.
- S&P 500 Pharma/Biotech: Forward P/E 15.9, portion of market cap 5.1%, 1-week performance 0.5%, 1-month 3.0%, 3-month 0.9%, YTD 9.0%.
- Nasdaq Biotechnology: Forward P/E 48.1, portion of market cap 2.3%, 1-week performance (0.5)%, 1-month 0.7%, 3-month (0.8)%, YTD 10.4%.
- S&P 500 Healthcare Equipment and Services: Forward P/E 18.4, portion of market cap 3.4%, 1-week performance 0.5%, 1-month 4.9%, 3-month 7.2%, YTD 19.0%.
Europe:
- MSCI Europe Healthcare: Forward P/E 17.5, portion of market cap 11.8%, 1-week performance 0.4%, 1-month (0.5)%, 3-month 4.1%, YTD 9.8%.
- MSCI Europe Pharm/Bio: Forward P/E 17.3, portion of market cap 10.1%, 1-week performance 0.3%, 1-month (1.1)%, 3-month 3.5%, YTD 9.5%.
- MSCI Europe Healthcare Equipment and Services: Forward P/E 24.1, portion of market cap 1.7%, 1-week performance 1.5%, 1-month 3.8%, 3-month 9.4%, YTD 12.3%.
Japan:
- MSCI Japan Healthcare: Forward P/E 24.1, portion of market cap 7.1%, 1-week performance 1.8%, 1-month (0.4)%, 3-month 0.4%, YTD 2.1%.
- MSCI Japan Pharm/Bio: Forward P/E 23.6, portion of market cap 5.1%, 1-week performance 2.1%, 1-month (1.3)%, 3-month (0.4)%, YTD 1.1%.
- Topix Pharma: Forward P/E 23.5, portion of market cap 4.7%, 1-week performance 2.3%, 1-month (1.0)%, 3-month 0.4%, YTD 2.1%.
- MSCI Japan Healthcare Equipment and Services: Forward P/E 25.1, portion of market cap 2.0%, 1-week performance 1.1%, 1-month 1.8%, 3-month 2.4%, YTD 4.5%.
China:
- MSCI China Healthcare: Forward P/E 19.4, portion of market cap 1.8%, 1-week performance (2.8)%, 1-month 2.0%, 3-month 6.3%, YTD 21.7%.
India:
- MSCI India Healthcare: Forward P/E 22.1, portion of market cap 6.2%, 1-week performance 0.1%, 1-month (6.1)%, 3-month (9.8)%, YTD (6.3)%.

Korean Healthcare Sector Analysis

Pharmaceutical Holdings

Hanmi Science: Market cap 5,618 KRWb, share price 90,200 KRW, P/E 449.3 (2016), P/B 5.4 (2016), 1-week performance 3.7%, 1-month 31.9%, 3-month 57.4%, YTD 57.5%, 1-week change (9.3)%.
Green Cross Holdings: Market cap 1,498 KRWb, share price 30,450 KRW, P/E 25.0 (2016), P/B 1.4 (2016), 1-week performance (9.0)%, 1-month (6.3)%, 3-month 19.9%, YTD 27.9%, 1-week change (16.6)%.
Donga Socio Holdings: Market cap 856 KRWb, share price 139,500 KRW, P/E 5.5 (2016), P/B 1.1 (2016), 1-week performance (10.6)%, 1-month (0.4)%, 3-month 16.7%, YTD (10.9)%, 1-week change (14.4)%.
Daewoong: Market cap 733 KRWb, share price 12,600 KRW, P/E 25.8 (2016), P/B 0.8 (2016), 1-week performance (15.7)%, 1-month 2.3%, 3-month 27.3%, YTD 42.6%, 1-week change (80.4)%.
JW Holdings: Market cap 625 KRWb, share price 10,100 KRW, P/E n/a (2016), P/B 4.6 (2016), 1-week performance 0.0%, 1-month 24.7%, 3-month 29.5%, YTD (13.7)%, 1-week change (6.5)%.
Chongkundang Holdings: Market cap 378 KRWb, share price 75,500 KRW, P/E 11.1 (2016), P/B 0.9 (2016), 1-week performance (7.9)%, 1-month 11.2%, 3-month 27.3%, YTD (9.6)%, 1-week change (9.6)%.

Pharmaceuticals

Hanmi Pharm: Market cap 4,471 KRWb, share price 400,500 KRW, P/E 136.7 (2016), P/B 4.8 (2016), 1-week performance (3.4)%, 1-month 10.0%, 3-month 36.7%, YTD 40.2%, 1-week change (6.1)%.
Yuhan: Market cap 2,823 KRWb, share price 238,500 KRW, P/E 14.7 (2016), P/B 1.4 (2016), 1-week performance (4.2)%, 1-month 0.0%, 3-month 13.8%, YTD 19.6%, 1-week change (5.9)%.
Young Jin Pharm: Market cap 2,277 KRWb, share price 12,450 KRW, P/E 372.8 (2016), P/B 14.8 (2016), 1-week performance (6.4)%, 1-month 33.4%, 3-month 51.8%, YTD 41.2%, 1-week change (6.4)%.
SK Chemicals (006280): Market cap 2,010 KRWb, share price 172,000 KRW, P/E 29.1 (2016), P/B 1.8 (2016), 1-week performance (4.7)%, 1-month (0.9)%, 3-month 11.7%, YTD 9.6%, 1-week change (7.5)%.
SK Chemicals (006120): Market cap 1,933 KRWb, share price 75,900 KRW, P/E 22.0 (2016), P/B 1.0 (2016), 1-week performance (1.9)%, 1-month 16.1%, 3-month 22.0%, YTD 13.3%, 1-week change (1.9)%.
Chong Kun Dang: Market cap 1,124 KRWb, share price 119,500 KRW, P/E 24.0 (2016), P/B 2.8 (2016), 1-week performance (5.5)%, 1-month (0.4)%, 3-month 14.9%, YTD 14.4%, 1-week change (6.3)%.
Daewoong Pharm: Market cap 1,006 KRWb, share price 86,800 KRW, P/E 29.5 (2016), P/B 1.4 (2016), 1-week performance (12.6)%, 1-month (8.9)%, 3-month 10.7%, YTD 26.4%, 1-week change (14.5)%.
Bukwang Pharmaceutical: Market cap 998 KRWb, share price 22,400 KRW, P/E 74.4 (2016), P/B 5.3 (2016), 1-week performance (4.1)%, 1-month 5.7%, 3-month 5.7%, YTD (27.7)%, 1-week change (15.2)%.
JW Pharmaceutical: Market cap 965 KRWb, share price 50,100 KRW, P/E n/a (2016), P/B 4.0 (2016), 1-week performance (3.8)%, 1-month 10.2%, 3-month 14.4%, YTD (4.9)%, 1-week change (7.4)%.
Donga ST: Market cap 817 KRWb, share price 96,800 KRW, P/E 83.3 (2016), P/B 2.9 (2016), 1-week performance (2.9)%, 1-month 2.9%, 3-month 7.0%, YTD (10.4)%, 1-week change (8.3)%.
Samjin Pharm: Market cap 477 KRWb, share price 34,300 KRW, P/E 16.0 (2016), P/B 2.6 (2016), 1-week performance (0.6)%, 1-month 0.6%, 3-month 7.4%, YTD (4.5)%, 1-week change (1.3)%.
Kwang Dong Pharm: Market cap 472 KRWb, share price 9,000 KRW, P/E 15.9 (2016), P/B 5.7 (2016), 1-week performance (4.5)%, 1-month 1.9%, 3-month 3.2%, YTD 5.6%, 1-week change (5.0)%.
Boryung Pharm: Market cap 462 KRWb, share price 52,300 KRW, P/E 97.6 (2016), P/B 5.8 (2016), 1-week performance (5.3)%, 1-month 5.8%, 3-month 6.2%, YTD (17.9)%, 1-week change (15.7)%.
Daewon Pharmaceutical: Market cap 368 KRWb, share price 20,200 KRW, P/E 17.1 (2016), P/B 1.5 (2016), 1-week performance (5.2)%, 1-month (1.7)%, 3-month (1.0)%, YTD (13.5)%, 1-week change (3.1)%.
Whan In Pharm: Market cap 346 KRWb, share price 18,600 KRW, P/E 18.0 (2016), P/B 1.1 (2016), 1-week performance (2.9)%, 1-month 9.4%, 3-month 23.6%, YTD (5.1)%, 1-week change (4.5)%.
Handok: Market cap 345 KRWb, share price 27,400 KRW, P/E n/a (2016), P/B 1.2 (2016), 1-week performance 1.1%, 1-month 17.6%, 3-month 18.4%, YTD (6.6)%, 1-week change (1.3)%.
Huons: Market cap 342 KRWb, share price 55,300 KRW, P/E 25.6 (2016), P/B 4.2 (2016), 1-week performance (8.8)%, 1-month (0.9)%, 3-month (13.3)%, YTD (13.3)%, 1-week change (13.3)%.
Korea United Pharm: Market cap 335 KRWb, share price 20,700 KRW, P/E 15.4 (2016), P/B 1.5 (2016), 1-week performance 3.2%, 1-month 4.3%, 3-month 20.4%, YTD 11.9%, 1-week change 0.0%.

APIs

Kolon Life Science: Market cap 1,318 KRWb, share price 173,200 KRW, P/E 67.5 (2016), P/B 3.4 (2016), 1-week performance (6.1)%, 1-month 19.3%, 3-month 62.8%, YTD 47.5%, 1-week change (9.2)%.
ST Pharm: Market cap 801 KRWb, share price 43,350 KRW, P/E 12.0 (2016), P/B 2.7 (2016), 1-week performance (13.1)%, 1-month (8.7)%, 3-month 2.9%, YTD (3.3)%, 1-week change (13.1)%.
Kyongbo Pharmaceutical: Market cap 329 KRWb, share price 13,750 KRW, P/E 26.3 (2016), P/B 2.6 (2016), 1-week performance (4.2)%, 1-month 1.5%, 3-month 10.4%, YTD (5.8)%, 1-week change (1.4)%.
Estech Pharma: Market cap 146 KRWb, share price 12,400 KRW, P/E 29.2 (2016), P/B 1.6 (2016), 1-week performance (2.4)%, 1-month 13.2%, 3-month 32.1%, YTD (16.4)%, 1-week change (6.8)%.
Daebong LS: Market cap 142 KRWb, share price 12,850 KRW, P/E 15.7 (2016), P/B 2.1 (2016), 1-week performance (3.8)%, 1-month (3.4)%, 3-month 12.7%, YTD (5.9)%, 1-week change (5.9)%.
CKD Bio: Market cap 122 KRWb, share price 23,350 KRW, P/E 13.1 (2016), P/B 0.9 (2016), 1-week performance (0.9)%, 1-month 2.9%, 3-month 6.4%, YTD (0.9)%, 1-week change (3.1)%.
Hwaili Pharm: Market cap 108 KRWb, share price 7,480 KRW, P/E 18.3 (2016), P/B 1.1 (2016), 1-week performance (1.7)%, 1-month 4.9%, 3-month 2.1%, YTD (7.8)%, 1-week change (8.7)%.

Industrial-use Enzymes

Amicogen: Market cap 378 KRWb, share price 41,500 KRW, P/E 255.6 (2016), P/B 5.0 (2016), 1-week performance (1.3)%, 1-month (5.9)%, 3-month 4.0%, YTD (11.4)%, 1-week change (6.9)%.
Genofocus: Market cap 172 KRWb, share price 19,100 KRW, P/E 111.5 (2016), P/B 3.4 (2016), 1-week performance (7.1)%, 1-month (1.8)%, 3-month (0.3)%, YTD (7.1)%, 1-week change (1.8)%.

Biosimilars

Samsung Biologics: Market cap 15,880 KRWb, share price 240,000 KRW, P/E n/a (2016), P/B 2.5 (2016), 1-week performance 6.9%, 1-month 28.3%, 3-month 36.0%, YTD 58.9%, 1-week change (2.0)%.
Celltrion: Market cap 12,788 KRWb, share price 104,300 KRW, P/E 73.8 (2016), P/B 6.4 (2016), 1-week performance 2.9%, 1-month 9.9%, 3-month 8.3%, YTD (3.6)%, 1-week change (3.6)%.
Binex: Market cap 373 KRWb, share price 11,900 KRW, P/E n/a (2016), P/B 3.6 (2016), 1-week performance 1.7%, 1-month (13.1)%, 3-month (29.8)%, YTD (3.3)%, 1-week change (3.3)%.
Alteogen: Market cap 198 KRWb, share price 31,500 KRW, P/E n/a (2016), P/B 4.5 (2016), 1-week performance 3.6%, 1-month 14.1%, 3-month 13.7%, YTD (4.8)%, 1-week change (4.8)%.
ISU Abxis: Market cap 152 KRWb, share price 7,680 KRW, P/E n/a (2016), P/B 3.7 (2016), 1-week performance (2.7)%, 1-month (3.0)%, 3-month 2.1%, YTD (10.3)%, 1-week change (10.3)%.
Chabiotech: Market cap 642 KRWb, share price 12,700 KRW, P/E 38.0 (2016), P/B 2.2 (2016), 1-week performance (1.2)%, 1-month (5.2)%, 3-month (1.0)%, YTD (7.0)%, 1-week change (7.0)%.
Medipost: Market cap 501 KRWb, share price 63,700 KRW, P/E n/a (2016), P/B 9.3 (2016), 1-week performance (7.3)%, 1-month (3.5)%, 3-month 9.7%, YTD (13.7)%, 1-week change (13.7)%.
Pharmicell: Market cap 88,100 KRWb, share price 4,180 KRW, P/E 243.7 (2016), P/B 7.2 (2016), 1-week performance 8.9%, 1-month 26.8%, 3-month 76.6%, YTD 90.7%, 1-week change (2.0)%.
Pharmicell (005690): Market cap 244 KRWb, share price 4,180 KRW, P/E n/a (2016), P/B 3.2 (2016), 1-week performance (5.5)%, 1-month (5.5)%, 3-month (8.8)%, YTD (19.5)%, 1-week change (19.5)%.
Anterogen: Market cap 185 KRWb, share price 23,300 KRW, P/E 471.7 (2016), P/B 5.2 (2016), 1-week performance 1.8%, 1-month 17.1%, 3-month 23.3%, YTD (3.1)%, 1-week change (3.1)%.
Kangstem Biotech: Market cap 167 KRWb, share price 11,600 KRW, P/E n/a (2016), P/B 6.7 (2016), 1-week performance 9.4%, 1-month 15.4%, 3-month 16.6%, YTD (2.1)%, 1-week change (2.1)%.
Corestem: Market cap 158 KRWb, share price 4,125 KRW, P/E n/a (2016), P/B 2.7 (2016), 1-week performance (1.0)%, 1-month (1.5)%, 3-month (1.6)%, YTD (13.7)%, 1-week change (13.7)%.

Immune Cell Therapy

Green Cross Cell: Market cap 380 KRWb, share price 32,500 KRW, P/E n/a (2016), P/B 8.1 (2016), 1-week performance 3.0%, 1-month 4.8%, 3-month 21.5%, YTD (13.1)%, 1-week change (13.1)%.
JW Shinyak: Market cap 319 KRWb, share price 8,110 KRW, P/E n/a (2016), P/B 8.2 (2016), 1-week performance (4.6)%, 1-month (5.7)%, 3-month 12.6%, YTD (10.3)%, 1-week change (10.3)%.
Green Cross Lab Cell: Market cap 278 KRWb, share price 26,300 KRW, P/E 102.9 (2016), P/B 5.5 (2016), 1-week performance (0.4)%, 1-month 3.1%, 3-month 5.6%, YTD (9.3)%, 1-week change (9.3)%.
Seegene: Market cap 993 KRWb, share price 37,850 KRW, P/E 128.7 (2016), P/B 6.4 (2016), 1-week performance (5.0)%, 1-month 0.3%, 3-month 16.1%, YTD (5.8)%, 1-week change (5.8)%.
Panagene: Market cap 197 KRWb, share price 6,170 KRW, P/E n/a (2016), P/B 9.6 (2016), 1-week performance 0.7%, 1-month 3.9%, 3-month (2.1)%, YTD (11.7)%, 1-week change (11.7)%.
Bioneer: Market cap 109 KRWb, share price 5,280 KRW, P/E n/a (2016), P/B 4.6 (2016), 1-week performance (1.0)%, 1-month (0.4)%, 3-month (1.5)%, YTD (16.6)%, 1-week change (16.6)%.
MG MED: Market cap 108 KRWb, share price 18,100 KRW, P/E n/a (2016), P/B 9.3 (2016), 1-week performance (12.6)%, 1-month 26.8%, 3-month 90.7%, YTD 73.4%, 1-week change 0.0%.

Diagnostics

Boditech Med: Market cap 449 KRWb, share price 19,300 KRW, P/E 34.6 (2016), P/B 5.8 (2016), 1-week performance 0.3%, 1-month 1.3%, 3-month 9.7%, YTD (12.1)%, 1-week change (12.1)%.
i-Sens: Market cap 389 KRWb, share price 28,350 KRW, P/E 23.0 (2016), P/B 2.7 (2016), 1-week performance (2.4)%, 1-month (0.4)%, 3-month (1.7)%, YTD (3.6)%, 1-week change (3.6)%.
Access Bio: Market cap 133 KRWb, share price 4,920 KRW, P/E 544.6 (2016), P/B 2.9 (2016), 1-week performance 1.3%, 1-month (0.2)%, 3-month (3.9)%, YTD (19.6)%, 1-week change (19.6)%.
Green Cross Medical Science: Market cap 119 KRWb, share price 12,400 KRW, P/E n/a (2016), P/B 3.9 (2016), 1-week performance 7.8%, 1-month 13.8%, 3-month 15.4%, YTD 13.2%, 1-week change 0.0%.

Genome Analysis

Macrogen: Market cap 271 KRWb, share price 28,700 KRW, P/E 68.3 (2016), P/B 3.5 (2016), 1-week performance (5.1)%, 1-month 0.9%, 3-month 12.8%, YTD (14.3)%, 1-week change (14.3)%.
Theragen Etex: Market cap 184 KRWb, share price 6,350 KRW, P/E 72.8 (2016), P/B 2.2 (2016), 1-week performance (1.2)%, 1-month 6.5%, 3-month 13.6%, YTD (2.5)%, 1-week change (2.5)%.
LabGenomics: Market cap 85 KRWb, share price 9,950 KRW, P/E 122.7 (2016), P/B 3.5 (2016), 1-week performance (0.1)%, 1-month 8.3%, 3-month 3.5%, YTD (11.2)%, 1-week change (11.2)%.
DNA Link: Market cap 26 KRWb, share price 4,100 KRW, P/E n/a (2016), P/B 23.6 (2016), 1-week performance 0.7%, 1-month 3.9%, 3-month (2.1)%, YTD (15.5)%, 1-week change (15.5)%.

New Drug Development

ViroMed: Market cap 1,628 KRWb, share price 102,000 KRW, P/E 2818.8 (2016), P/B 7.5 (2016), 1-week performance 0.4%, 1-month 11.2%, 3-month 12.8%, YTD (12.1)%, 1-week change (12.1)%.
Sillajen: Market cap 1,520 KRWb, share price 23,700 KRW, P/E n/a (2016), P/B 4.0 (2016), 1-week performance 47.7%, 1-month 122.5%, 3-month 108.8%, YTD 78.9%, 1-week change 0.0%.
Genexine: Market cap 877 KRWb, share price 49,150 KRW, P/E n/a (2016), P/B 4.9 (2016), 1-week performance 0.3%, 1-month 21.4%, 3-month 28.0%, YTD 13.9%, 1-week change (6.9)%.
HLB: Market cap 500 KRWb, share price 13,900 KRW, P/E n/a (2016), P/B 5.3 (2016), 1-week performance 0.4%, 1-month 1.1%, 3-month 6.4%, YTD (18.2)%, 1-week change (18.2)%.
Intron Biotechnology: Market cap 444 KRWb, share price 29,500 KRW, P/E n/a (2016), P/B 5.9 (2016), 1-week performance 5.4%, 1-month 20.4%, 3-month 22.9%, YTD (11.8)%, 1-week change (11.8)%.
CrystalGenomics: Market cap 414 KRWb, share price 16,000 KRW, P/E n/a (2016), P/B 5.3 (2016), 1-week performance 3.9%, 1-month 4.2%, 3-month 11.1%, YTD (11.1)%, 1-week change (11.1)%.
GemVax & Kael: Market cap 408 KRWb, share price 13,350 KRW, P/E n/a (2016), P/B 8.3 (2016), 1-week performance (4.3)%, 1-month 1.1%, 3-month 9.0%, YTD (8.3)%, 1-week change (8.3)%.
Legochem Biosciences: Market cap 359 KRWb, share price 36,100 KRW, P/E n/a (2016), P/B 5.9 (2016), 1-week performance 0.6%, 1-month 12.9%, 3-month 23.6%, YTD (3.1)%, 1-week change (3.1)%.
Pepton: Market cap 314 KRWb, share price 47,250 KRW, P/E n/a (2016), P/B 5.4 (2016), 1-week performance 3.5%, 1-month 7.9%, 3-month 21.2%, YTD (2.6)%, 1-week change (2.6)%.
Quirient: Market cap 278 KRWb, share price 37,050 KRW, P/E n/a (2016), P/B 10.4 (2016), 1-week performance 5.3%, 1-month 42.2%, 3-month 53.4%, YTD (1.9)%, 1-week change (1.9)%.
Eyegene: Market cap 126 KRWb, share price 12,550 KRW, P/E n/a (2016), P/B 7.0 (2